UK: ASTRAZENECA LAUNCHES CLINICAL TRIAL OF COVID-19 DRUG

LONDON: Pharma giant Astrazeneca said on Tuesday it has begun a trial of a drug designed to prevent infection and treat people with Covid-19, with the first volunteers receiving doses. The drug is a combination of two antibodies and is being tested on 48 healthy people aged between 18 and 55. The company said the trial would help evaluate the safety of the drug and be used both to prevent the disease and to stop it from progressing in patients infected.